InvestorsHub Logo
Followers 65
Posts 11443
Boards Moderated 0
Alias Born 10/20/2009

Re: honestabe13 post# 213790

Tuesday, 03/31/2015 11:10:20 AM

Tuesday, March 31, 2015 11:10:20 AM

Post# of 346050
honest et al....after private conversations I want to CLARIFY and HAMMER HOME....The CA does NOT effect the release of news except in the case of the CA itself. Any and ALL material information will be PRd according to SEC rules and regs. It was also noted, as in the case of the liver data that NOTHING changed from the previous info, hence no PR. "Strategic" reasons will effect the release of what we may see as material info but the SEC rules and regs do not. "Strategic" regarding data due to upcoming conferences and or publications.

Sunrise Trial enrollment info is also "strategic" in nature.

It seems a like a very fine line but material is material is material but bound to be interpreted by us.


Just look at the facts of "missing" PRs. Betabodies Patent, Liver Presentation...breast is very questionable as material because as stated...PEER REVIEWED does seem to be a MATERIAL EVENT in the CERTIFICATION of Bavituximabs MOA and actual effectiveness.

I'm trying to understand all this as much as anyone but it is what it is.
Take it for what it's worth.

wook


Best of $RESULTS for Humanity, FDA Approval(s), Partner(s) Production, Imaging and MOST IMPORTANTLY!!!
Research.
Always looking deeper. RIP Dr. Thorpe

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News